DevMesh

RespiScan 2.0

Abhinav Rathi

Abhinav Rathi

Unknown

0 0

RespiScan 2.0 is a groundbreaking project aimed at enhancing lung cancer prediction through two innovative modes of analysis. Leveraging the power of Intel oneAPI, RespiScan 2.0 offers a comprehensive approach to early detection and prevention of lung cancer. ...learn more

Project status: Under Development

oneAPI, Artificial Intelligence, Cloud

Intel Technologies
DevCloud, oneAPI, Intel Python, Intel CPU

Code Samples [1]Links [1]

Overview / Usage

Project Overall:

RespiScan 2.0 is an innovative and comprehensive project aimed at lung cancer prediction and prevention through the integration of machine learning classification models and image analysis techniques. This advanced system provides users with accurate predictions regarding the likelihood of lung cancer based on a diverse set of variables, while also offering personalized prevention and cure recommendations.

Key Features:

1. Machine Learning Classification Models: RespiScan 2.0 employs a powerful ensemble of 9 distinct machine learning classification models, implemented using the Scikit-learn library in Python. These models include Logistic Regression, Decision Tree, K-Nearest Neighbor, Gaussian Naive Bayes, Multinomial Naive Bayes, Support Vector Classifier, Random Forest, Multi-layer Perceptron, and Gradient Boosting Classifier. These algorithms work in synergy to predict the probability of lung cancer based on a comprehensive dataset.

2. Dataset and Variables: The system utilizes a meticulously curated dataset containing various critical attributes including gender, age, smoking history, yellow fingers (a potential smoking-related indicator), anxiety levels, peer pressure exposure, history of chronic diseases, fatigue levels, allergies, wheezing frequency, alcohol consumption, coughing intensity, shortness of breath, swallowing difficulty, chest pain occurrences, and lung cancer status. These variables contribute to a holistic assessment of the user's potential risk.

3. CT Scan Image Analysis: In addition to the machine learning models, RespiScan 2.0 employs cutting-edge image analysis techniques. Using the ResNet50 model, the system performs in-depth analysis of CT scan images to identify potential anomalies or signs of lung cancer. This mode of analysis adds a layer of precision and comprehensiveness to the overall prediction process.

4. Prevention and Cure Recommendations: Upon completion of the prediction process, RespiScan 2.0 takes a holistic approach by providing users with personalized prevention and cure recommendations. These recommendations are based on the predicted likelihood of lung cancer, individual risk factors, and historical data. Users receive actionable steps and guidance to reduce their risk and promote lung health.

5. User-Friendly Interface: RespiScan 2.0 features an intuitive and user-friendly interface that facilitates easy input of user data and CT scan images. The system presents prediction results and recommendations in a clear and understandable manner, enabling users to make informed decisions about their lung health.

RespiScan 2.0 represents a significant leap forward in lung cancer prediction and prevention. By seamlessly integrating machine learning models and image analysis, the system provides users with a comprehensive and personalized assessment of their lung cancer risk, empowering them to take proactive steps towards a healthier life.

​

Problem being Solved:

Lung cancer is a serious and common disease that affects millions of people around the world. It is caused by genetic damage to the cells in the lungs, often due to smoking or exposure to harmful substances. Lung cancer can cause symptoms such as difficulty breathing, coughing up blood, chest pain, hoarseness, headache and weight loss. Lung cancer can be diagnosed by various tests such as X-rays, CT scans, MRI scans, PET scans, sputum cytology and biopsy. Lung cancer can be treated by surgery, chemotherapy and radiation therapy, depending on the type and stage of the cancer.

The inspiration for doing this project on lung cancer is to raise awareness about this disease and its prevention. Lung cancer is the leading cause of cancer deaths worldwide, but many people are unaware of its risk factors and symptoms.

Additionally, the RespiScan 2.0 project could potentially be used for public health education and awareness campaigns. By highlighting the risk factors and symptoms of lung cancer, the model could help raise awareness and encourage individuals to take steps to reduce their risk of developing the disease. This could include initiatives to promote smoking cessation, improve air quality in workplaces, and encourage early detection and treatment through regular screenings.

However, it is important to note that any diagnostic tool, including the RespiScan 2.0 model, would need to be thoroughly validated and tested before being used in a clinical setting. This would involve testing the model on a large and diverse population of patients to ensure that it is accurate and reliable across different demographics and patient groups.

Overall, the RespiScan 2.0 project has the potential to improve the early detection and treatment of lung cancer, which could have significant benefits for patient health and survival rates. However, further research and testing would be needed to ensure that the model is accurate and reliable for use in a clinical setting.

​

How is the Work is experienced or used in production:

RespiScan 2.0 can be experienced and used in production as a user-friendly tool for individuals who want to assess their risk of developing lung cancer from the comfort of their own homes. Users can input their basic information and symptoms into the RespiScan 2.0 model, and receive a prediction of their likelihood of having lung cancer.

The model could be integrated into a web-based platform or mobile application, which could be easily accessed by users. The platform could also provide educational resources on lung cancer prevention and early detection, which could help users reduce their risk of developing the disease.

Overall, RespiScan 2.0 has the potential to be a valuable tool for individuals who are concerned about their risk of developing lung cancer, as it can provide a quick and convenient way to assess their risk and take appropriate action to prevent or detect the disease.

Methodology / Approach

The development of RespiScan 2.0 involves a carefully crafted methodology that integrates machine learning and image analysis techniques to predict lung cancer likelihood and provide tailored prevention and cure recommendations. The project follows a systematic approach to ensure accuracy, reliability, and user-friendliness.

1. Data Collection and Preprocessing:

  • Curate a diverse dataset containing relevant attributes such as gender, age, smoking history, lifestyle factors, symptoms, and lung cancer status.
  • Clean and preprocess the dataset to handle missing values, outliers, and ensure uniform data formatting.
  • Perform exploratory data analysis (EDA) to gain insights into data distributions, correlations, and potential biases.

2. Feature Selection and Engineering:

  • Identify key features that contribute significantly to lung cancer prediction using statistical analysis and domain expertise.
  • Create new features through feature engineering techniques to enhance model performance and capture complex relationships.

3. Machine Learning Model Selection and Implementation:

  • Choose a set of 9 machine learning classification algorithms including Logistic Regression, Decision Tree, K-Nearest Neighbor, Gaussian Naive Bayes, Multinomial Naive Bayes, Support Vector Classifier, Random Forest, Multi-layer Perceptron, and Gradient Boosting Classifier.
  • Split the dataset into training and testing sets for model training and evaluation.
  • Implement each algorithm using the Scikit-learn library and optimize hyperparameters through techniques like grid search or randomized search.

4. CT Scan Image Analysis using ResNet50:

  • Preprocess CT scan images to standardize dimensions, normalize pixel values, and enhance contrast.
  • Utilize the pre-trained ResNet50 convolutional neural network (CNN) model for image analysis.
  • Fine-tune the ResNet50 model on a subset of CT scan images to adapt it for lung cancer detection.
  • Extract high-level features from CT scan images using the trained ResNet50 model.

5. Integration and Ensemble:

  • Combine predictions from the machine learning models and the ResNet50 image analysis to create an ensemble prediction.
  • Assign appropriate weights to individual model predictions based on their performance and relevance.
  • Apply a fusion technique (e.g., weighted average or majority voting) to combine the ensemble predictions.

6. Prediction and Recommendation Generation:

  • Predict the likelihood of lung cancer for each user based on the ensemble model's output.
  • Generate personalized prevention and cure recommendations using a rule-based system that considers the user's predicted risk, demographic information, and lifestyle factors.
  • Present prediction results and recommendations in a user-friendly interface.

7. Model Evaluation and Validation:

  • Evaluate the performance of individual machine learning models and the ensemble using metrics such as accuracy, precision, recall, F1-score, and area under the ROC curve.
  • Validate the image analysis component using a separate set of labeled CT scan images and performance evaluation metrics specific to image classification tasks.

8. User Testing and Iteration:

  • Conduct user testing sessions to gather feedback on the system's usability, accuracy, and comprehensibility.
  • Incorporate user feedback to improve the system's interface, prediction accuracy, and recommendation relevance.
  • Iterate on the model training, preprocessing, and analysis based on the insights gained from user testing.

9. Deployment and Maintenance:

  • Deploy the RespiScan 2.0 system to a secure and scalable environment.
  • Continuously monitor and update the system to incorporate new data, improve model performance, and adapt to emerging trends and advancements in lung cancer research.

RespiScan 2.0's methodology combines the strengths of machine learning algorithms and advanced image analysis techniques, providing users with a comprehensive and accurate lung cancer prediction and prevention solution. The iterative and user-centered approach ensures that the system remains effective and relevant in promoting lung health.

Technologies Used

Programming Language:

  • Python: The core programming language used for developing RespiScan 2.0, encompassing both machine learning algorithm implementation and web development.

Machine Learning Algorithms and Libraries:

  • Logistic Regression, Decision Tree, K-Nearest Neighbor, Gaussian Naive Bayes, Multinomial Naive Bayes, Support Vector Classifier, Random Forest, Multi-layer Perceptron, Gradient Boosting Classifier: These algorithms are implemented using the Scikit-learn library for training and predicting lung cancer likelihood.
  • ResNet50: A pre-trained deep learning model from the Keras library, used for CT scan image analysis.

Web Development:

  • Flask: A lightweight and versatile web framework for Python, used to build the user interface, handle user requests, and display prediction results.
  • HTML/CSS/JavaScript: These front-end technologies are employed to create an interactive and visually appealing user interface.

Data Manipulation and Analysis:

  • Pandas: A powerful library for data manipulation and analysis, utilized for loading, cleaning, preprocessing, and exploring the dataset.
  • NumPy: A fundamental library for numerical computations, employed for array operations and mathematical functions.

Data Visualization:

  • Matplotlib and Seaborn: These visualization libraries are used to create informative charts, graphs, and plots to present data insights.

Cross-Origin Resource Sharing (CORS):

  • Flask-CORS: An extension for Flask that enables cross-origin resource sharing, facilitating communication between the front-end and back-end components.

Interactive Data Analysis and Prototyping:

  • Jupyter Notebook: An interactive environment for data analysis, visualization, and prototyping, used for experimenting with code and algorithms.

Integrated Development Environment (IDE):

  • Visual Studio Code: A popular IDE for Python development, offering features like code editing, debugging, and version control integration.

Version Control and Collaboration:

  • Git and GitHub: These tools are used for version control, allowing multiple developers to collaborate on the project and track changes.

Package Management and Environment Setup:

  • Anaconda: A platform that simplifies package management and environment setup, ensuring consistent dependencies and configurations.

Cloud Hosting:

  • Amazon Web Services (AWS): The website developed using Flask is hosted on AWS, making it accessible to users from anywhere.

Model Deployment:

  • Streamer.io: The machine learning models, including the ensemble model and ResNet50, are deployed using Streamer.io, allowing for easy integration into the web application.

Hardware and Operating System:

  • Personal Computer or Server: The development and deployment of RespiScan 2.0 require a computer or server with sufficient processing power and memory.
  • Operating System: The project can be developed and deployed on various operating systems, including Windows, macOS, or Linux.

RespiScan 2.0 leverages a diverse set of technologies to create an integrated and efficient system that predicts lung cancer likelihood, provides prevention recommendations, and offers an intuitive user experience through a web interface hosted on AWS. The combination of programming languages, libraries, frameworks, and tools contributes to the project's success in delivering accurate predictions and valuable insights for users.

Repository

https://github.com/Abhinav00711/RespiScan-2.0

Collaborators

1 Result

1 Result

Comments (0)